Results 91 to 100 of about 25,027 (259)

Hypophosphatemia after hemodialysis and its association with some clinical complications in patients with chronic kidney disease

Caspian Journal of Internal Medicine, 2022
Background: Beyond the adverse effects of hyperphosphatemia in patients with chronic kidney disease (CKD(, hypophosphatemia has also been proposed as a common challenge after dialysis.
Mohammadreza Ardalan, Ali Safaei, Audrey Tolouian, Ramin Tolouian, Vahideh Ebrahimzadeh-Attari, Mahsa Jalili   +5 more
doaj  

Dentoalveolar Defects in the Hyp Mouse Model of X-linked Hypophosphatemia

Journal of dentistry research, 2020
Mutations in PHEX cause X-linked hypophosphatemia (XLH), a form of hypophosphatemic rickets. Hyp (Phex mutant) mice recapitulate the XLH phenotype. Dental disorders are prevalent in individuals with XLH; however, underlying dentoalveolar defects remain ...
H. Zhang, Michael B Chavez, T. N. Kolli, M. Tan, H. Fong, E. Chu, Y. Li, X. Ren, K. Watanabe, D. Kim, B. Foster   +10 more
semanticscholar   +1 more source

A Giant Parathyroid Adenoma Presenting as Coughs and Dyspnea in a Young Woman: A Case Report

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT A parathyroid adenoma is defined as a benign tumor in the parathyroid glands. A type of parathyroid adenoma is giant parathyroid adenoma that weighs > 3.5 g and has a size of more than 2 cm. A 37‐year‐old woman presented with coughs and dyspnea without fever, hemoptysis, and weight loss. Examination of the patient revealed a diffusely enlarged
Somayeh Chahkandi, Nasrin Amiri‐Dashatan, Mehdi Koushki, Mojgan Sanjari   +3 more
wiley   +1 more source

A case of hypophosphatemia and elevated intact fibroblast growth factor 23 levels after short-term saccharated ferric oxide administration in a young woman and database analysis of adverse drug reactions in Japan

Bone Reports
Intravenous iron replacement therapy is a common treatment for iron deficiency. Commonly used agents in this treatment include ferric carboxymaltose, ferric derisomaltose, and saccharated ferric oxide (SFO).
Teruhisa Kinoshita, Yuki Kondo, Yuka Sakazaki, Hiroki Imaizumi, Norio Takimoto, Yoichi Ishitsuka   +5 more
doaj   +1 more source

Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours

Clinical and Translational Medicine, Volume 16, Issue 1, January 2026.
Evidence suggests NOTCH activation is among the survival and proliferation pathways interacting with FOXL2 c.402C > G (p.Cys134Trp) mutation in granulosa cell tumours (GCT). This Phase II clinical trial of nirogacestat in GCT achieved its enrolment target in < 1 year and primary analysis within 2 years.
Rachel N. Grisham, Elizabeth Hopp, Kathryn Pennington, Robert Holloway, Robert M. Wenham, Pawel Blecharz, Lauren Dockery, Koji Matsuo, Ritu Salani, Mariusz Bidzinski, Patricia Braly, Paul Celano, Thomas Reid, Shelly Seward, Jocelyn Lewis, Mark Johnson, Robert DuBose, Sarah Ahn, Shinta Cheng, Carmelita Alvero, Panagiotis A. Konstantinopoulos   +20 more
wiley   +1 more source

Unveiling the heightened susceptibility: Exploring early hypophosphatemia in critically ill trauma patients

Journal of the Formosan Medical Association
Background: Phosphorus is a vital mineral crucial for various physiological functions. Critically ill trauma patients frequently experience hypophosphatemia during the immediate post-traumatic phase, potentially impacting outcomes.
Chi-Ju Yang, Chia-Ming Chang, Gyu-Ping Chang, Huei-Ting Tsai, Ting-Yu Yu, Yin-Yi Han   +5 more
doaj   +1 more source

Iatrogenic Persistent Hypophosphatemia In A Simultaneous Liver-Kidney Transplant Recipient

Kidney Research and Clinical Practice, 2012
Hypophosphatemia from renal phosphate wasting during the immediate postoperative kidney transplant period is common and improves with supplementation.
Ekamol Tantisattamo, Satyanarayana Chekuri   +1 more
doaj   +1 more source

Burosumab Provides Sustained Improvement in Phosphorus Homeostasis and Heals Rickets in Children Aged 1 to 4 Years With X-Linked Hypophosphatemia (XLH) [PDF]

, 2021
Gary S. Gottesman, Erik A. Imel, Thomas O. Carpenter, Angel Chen, Alison Skrinar, Mary Scott Roberts, Michael P. Whyte   +6 more
openalex   +1 more source

Use of Extracorporeal Therapies to Treat Severe Caffeine Poisoning

Hemodialysis International, Volume 30, Issue 1, Page 73-79, January 2026.
ABSTRACT Introduction Reflecting on recent reports suggesting the efficacy of extracorporeal blood purification, including hemodialysis, for severe caffeine poisoning, we conducted a retrospective 5‐year follow‐up study on acute caffeine poisoning in Japan particularly focusing on extracorporeal blood purification.
Saeko Kohara, Yoshito Kamijo, Michiko Takai, Ryoko Kyan, Eiju Hasegawa, Takuya Shimane   +5 more
wiley   +1 more source

Association between hypoalbuminemia and hypophosphatemia with malnutrition in patients with chronic renal disease undergoing hemodialysis

Revista de la Facultad de Medicina Humana, 2020
Introduction: Malnutrition in hemodialysis patients is a consequence of various deficiency andhypercatabolic factors and constitutes a risk factor for morbidity and mortality.
Edwin Castillo Velarde, Gloria Montero Pacora, Sandra García Llajaruna   +2 more
doaj   +1 more source